Literature DB >> 1984621

28-day survival rates of 6676 neonates with birth weights of 1250 grams or less.

D L Phelps1, D R Brown, B Tung, G Cassady, R E McClead, D M Purohit, E A Palmer.   

Abstract

Survival rates specific for birth weight, gestational age, sex, and race are described for 6676 inborn neonates who weighed less than 1251 g at birth and were born during 1986 through 1987. Overall 28-day survival increased with gestational age and birth weight, from 36.5% at 24 weeks' gestation to 89.9% at 29 weeks' gestation, or from 30.0% for neonates of 500 through 599 g birth weight to 91.3% for neonates of 1200 through 1250 g. The expected birth weight-specific survival advantage for female neonates and black neonates diminished when the data were controlled for gestational age, showing that certain previously reported survival advantages are based on lower birth weight for a given gestational age. Multivariate analysis showed that all tested variables were significant predictors for survival, in order of descending significance: gestational age and birth weight, sex, race, single birth, and small-for-gestational-age status. The powerful effect of gestational age on survival highlights the need for an accurate neonatal tool to assess the gestational age of very low birth weight neonates after birth.

Entities:  

Mesh:

Year:  1991        PMID: 1984621

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  13 in total

1.  Neonatal complications of extreme prematurity in mechanically ventilated infants.

Authors:  V Chan; A Greenough; H R Gamsu
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  What do you do about ROP screening in "big" babies?

Authors:  G E Quinn
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

Review 3.  Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies.

Authors:  Gerd Holmström; Peter van Wijngaarden; Douglas J Coster; Keryn A Williams
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

4.  Treatment of preterm infants at the lower margin of viability--a comparison of guidelines in German speaking countries.

Authors:  Roland Hentschel; Stella Reiter-Theil
Journal:  Dtsch Arztebl Int       Date:  2008-01-18       Impact factor: 5.594

5.  Artificial neural network for risk assessment in preterm neonates.

Authors:  B Zernikow; K Holtmannspoetter; E Michel; W Pielemeier; F Hornschuh; A Westermann; K H Hennecke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

6.  Neonatal outcomes of very preterm infants admitted to a tertiary center in Lithuania between the years 2003 and 2005.

Authors:  Rita Jakuskiene; Brigitte Vollmer; Viktoras Saferis; Dalia Daugeliene
Journal:  Eur J Pediatr       Date:  2011-03-15       Impact factor: 3.183

7.  Early outcome of preterm infants with birth weight of 1500 g or less and gestational age of 30 weeks or less in Isfahan city, Iran.

Authors:  Fakhri Navaei; Banafsheh Aliabady; Javad Moghtaderi; Masoud Moghtaderi; Roya Kelishadi
Journal:  World J Pediatr       Date:  2010-06-12       Impact factor: 2.764

8.  A population based, prospective study of the development of ROP in prematurely born children in the Stockholm area of Sweden.

Authors:  G Holmström; M el Azazi; L Jacobson; G Lennerstrand
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

9.  Management of the woman with threatened birth of an infant of extremely low gestational age. Fetus and Newborn Committee, Canadian Paediatric Society, Maternal-Fetal Medicine Committee, Society of Obstetricians and Gynaecologists of Canada.

Authors: 
Journal:  CMAJ       Date:  1994-09-01       Impact factor: 8.262

10.  Actuarial survival of a large Canadian cohort of preterm infants.

Authors:  Huw P Jones; Stella Karuri; Catherine M G Cronin; Arne Ohlsson; Abraham Peliowski; Anne Synnes; Shoo K Lee
Journal:  BMC Pediatr       Date:  2005-11-09       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.